Alembic Pharmaceuticals informs about press release

10 Jun 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. In this regard, the company has attached a press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

761.30 -9.55 (-1.24%)
24-Feb-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1731.85
Dr. Reddys Lab 1305.00
Cipla 1328.80
Zydus Lifesciences 906.20
Lupin 2246.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×